(MENAFN- PR Newswire)
GOTHENBURG, Sweden, Oct. 24, 2024 /PRNewswire/ --
Third quarter
Sales of SEK 867 (848) million, an increase of 7% in local currencies and 2% in SEK.
Sales per region, in local currencies was +9% in EMEA, +2% in Americas and +9% in APAC.
Sales per business area, in local currencies was +13% in Consumables, +11% in Technologies and 0% in Genetics.
Gross margin increased to 58.6% (55.7).
Operating income before depreciation and amortisation (EBITDA) was SEK 289 (287) million, giving an EBITDA margin of 33.4% (33.9).
Operating cash flow decreased to SEK 206 million (214).
Net income was SEK 116 (122) million, resulting in earnings per share of SEK 0.85 (0.90).
First nine months
Sales of SEK 2,650 (2,607) million, an increase of 4% in local currencies and 2% in SEK.
Sales per region, in local currencies was +6% in EMEA, -2% in Americas and +7% in APAC.
Sales per business area, in local currencies was +10% in Consumables, +20% in Technologies and -7% in Genetics.
Gross margin increased to 58.6% (56.1).
Operating income before depreciation and amortisation (EBITDA) increased to SEK 888 (842) million, giving an EBITDA margin of 33.5% (32.3).
Operating cash flow increased to SEK 640 million (586).
Net income was SEK 375 (328) million, resulting in earnings per share of SEK 2.76 (2.42).
Gothenburg, October 24, 2024
VITROLIFE AB (publ)
Bronwyn Brophy O ́Connor, CEO
The information was submitted for publication, through the agency of the contact persons set out above, at
24-10-2024 08:00 CET.
Contact:
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision
,c4055545
The following files are available for download:
SOURCE Vitrolife AB
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN24102024003732001241ID1108814246
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment